These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35746595)

  • 1. A Novel Sphingosine Kinase Inhibitor Suppresses Chikungunya Virus Infection.
    Oyewole OO; Dunnavant K; Bhattarai S; Kharel Y; Lynch KR; Santos WL; Reid SP
    Viruses; 2022 May; 14(6):. PubMed ID: 35746595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
    Varghese FS; Thaa B; Amrun SN; Simarmata D; Rausalu K; Nyman TA; Merits A; McInerney GM; Ng LFP; Ahola T
    J Virol; 2016 Nov; 90(21):9743-9757. PubMed ID: 27535052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine kinase 2 is a chikungunya virus host factor co-localized with the viral replication complex.
    Reid SP; Tritsch SR; Kota K; Chiang CY; Dong L; Kenny T; Brueggemann EE; Ward MD; Cazares LH; Bavari S
    Emerg Microbes Infect; 2015 Oct; 4(10):e61. PubMed ID: 26576339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor library.
    Cruz DJ; Bonotto RM; Gomes RG; da Silva CT; Taniguchi JB; No JH; Lombardot B; Schwartz O; Hansen MA; Freitas-Junior LH
    PLoS Negl Trop Dis; 2013; 7(10):e2471. PubMed ID: 24205414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiling of chikungunya virus-infected human muscle cells: reveal the role of cytoskeleton network in CHIKV replication.
    Issac TH; Tan EL; Chu JJ
    J Proteomics; 2014 Aug; 108():445-64. PubMed ID: 24933005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus.
    Souza BG; Choudhary S; Vilela GG; Passos GFS; Costa CACB; Freitas JD; Coelho GL; Brandão JA; Anderson L; Bassi ÊJ; Araújo-Júnior JX; Tomar S; Silva-Júnior EFD
    Eur J Med Chem; 2023 Oct; 258():115572. PubMed ID: 37364511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
    Akhrymuk I; Lukash T; Frolov I; Frolova EI
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of tyrphostin AG879 and A9 inhibiting replication of chikungunya virus by screening of a kinase inhibitor library.
    He Y; Pan Z; Liu Y; Jiang L; Peng H; Zhao P; Qi Z; Liu Y; Tang H
    Virology; 2023 Nov; 588():109900. PubMed ID: 37832343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.
    Kaur P; Thiruchelvan M; Lee RC; Chen H; Chen KC; Ng ML; Chu JJ
    Antimicrob Agents Chemother; 2013 Jan; 57(1):155-67. PubMed ID: 23275491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
    Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.
    Varghese FS; Kaukinen P; Gläsker S; Bespalov M; Hanski L; Wennerberg K; Kümmerer BM; Ahola T
    Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and development of labdane-oxindole hybrids as small-molecule inhibitors against chikungunya virus infection.
    Tran QTN; Lee RCH; Liu HJ; Ran D; Low VZL; To DQ; Chu JJH; Chai CLL
    Eur J Med Chem; 2022 Feb; 230():114110. PubMed ID: 35085859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Strategies Against Chikungunya Virus.
    Abdelnabi R; Neyts J; Delang L
    Methods Mol Biol; 2016; 1426():243-53. PubMed ID: 27233277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic strategies to control chikungunya virus infection.
    Hucke FIL; Bestehorn-Willmann M; Bugert JJ
    Virus Genes; 2021 Apr; 57(2):133-150. PubMed ID: 33590406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host ESCRT factors are recruited during chikungunya virus infection and are required for the intracellular viral replication cycle.
    Torii S; Orba Y; Sasaki M; Tabata K; Wada Y; Carr M; Hobson-Peters J; Hall RA; Takada A; Fukuhara T; Matsuura Y; Hall WW; Sawa H
    J Biol Chem; 2020 Jun; 295(23):7941-7957. PubMed ID: 32341071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activity of nobiletin against chikungunya virus in vitro.
    Lin SC; Chen MC; Li S; Lin CC; Wang TT
    Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.
    Henß L; Beck S; Weidner T; Biedenkopf N; Sliva K; Weber C; Becker S; Schnierle BS
    Virol J; 2016 Aug; 13(1):149. PubMed ID: 27581733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication.
    Policastro LR; Dolci I; Godoy AS; Silva Júnior JVJ; Ruiz UEA; Santos IA; Jardim ACG; Samby K; Burrows JN; Wells TNC; Gil LHVG; Oliva G; Fernandes RS
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.